AstraZeneca beats US shareholder lawsuit over COVID vaccine disclosures Ruchika Sharma13 Sept 2022 4:00 PM ISTUS District Judge Paul Oetken said AstraZeneca and its executives had no "generalized duty" to disclose "negative facts" about the trials.
AstraZeneca Lynparza shows clinically meaningful survival benefit in 1st-line advanced ovarian cancer across two Phase III trials Ruchika Sharma11 Sept 2022 1:15 PM ISTOvarian cancer is one of the most common gynaecologic cancers, with a poor prognosis and a high mortality rate.
AstraZeneca Forxiga gets Chinese nod to treat CKD with and without type 2 diabetes Ruchika Sharma6 Sept 2022 11:15 AM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
AstraZeneca gets USFDA nod for Imfinzi plus chemotherapy to treat advanced biliary tract cancer Ruchika Sharma5 Sept 2022 1:30 PM ISTBiliary tract cancer is a group of rare and aggressive cancers that occur in the bile ducts and gallbladder.
AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer Ruchika Sharma30 Aug 2022 9:45 AM ISTNew Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...
Siam Bioscience reports record profit after COVID vaccine deal with AstraZeneca Ruchika Sharma29 Aug 2022 10:45 AM ISTBangkok: Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began...
AstraZeneca gets Japenese nod for Ultomiris to treat generalised myasthenia gravis Ruchika Sharma29 Aug 2022 9:30 AM ISTgMG is a rare, debilitating, chronic, autoimmune neuromuscular disease that leads to a loss of muscle function and severe weakness.
AstraZeneca, MSD get Japenese nod for breast cancer drug Lynparza Ruchika Sharma28 Aug 2022 11:45 AM ISTBreast cancer is the most diagnosed cancer worldwide with an estimated 2.3 million patients diagnosed in 2020.
AstraZeneca may not stay in vaccine business in long run: CEO Ruchika Sharma24 Aug 2022 2:57 PM ISTAstraZeneca is also looking for bolt-on acquisitions, including small and mid-sized companies specialising in oncology and cardiovascular treatments,...
AstraZeneca anticancer drug Trastuzumab Deruxtecan protocol amendment proposal approved by CDSCO panel Roshni Dhar23 Aug 2022 6:30 PM ISTBased on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug Standard Control...
Health Bulletin 23/August/2022 Roshni Dhar23 Aug 2022 5:18 PM ISTHere are the top health news for the day:'Tomato fever' misleading colloquial name for hand, foot and mouth disease Medical professional has informed...
AstraZeneca India breast cancer drug lynparza gets DCGI okay Isra Zaman22 Aug 2022 5:15 PM ISTAstraZeneca India, a science-led biopharmaceutical company, has announced that it has received a Drugs Controller General of India (DCGI) approval to...
